NCT04072250已完成不适用
Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?
Chang Gung Memorial Hospital1 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2017年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 216
- 试验地点
- 1
- 主要终点
- Survival
研究概览
简要总结
The investigators retrospectively reviewed the participants suffering from recurrent intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive factors for recurrence and clarify the potential benefit of repeat hepatectomy or/with metastasectomy.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •R0 resection for intrahepatic cholangiocarcinoma at initial diagnosis.
排除标准
- •(1)Patient with R1 or R2 resection
- •(2)Distant metastasis noted when laparotomy
- •(3)Surgical mortality
结局指标
主要结局
Survival
时间窗: 1977~2014
Including overall survival and disease free survival
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Hepatocarcinoma Recurrence on the Liver Study - Part2SurgeryRecurrence TumorLiver CancerCirrhosisNCT04053231University of Milano Bicocca3,000
已完成
不适用
Intraoperative Chemotherapy Against Hepatocellular Carcinoma RecurrenceHepatocellular CarcinomaNCT00817895Eastern Hepatobiliary Surgery Hospital150
招募中
不适用
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative TreatmentHepatocellular CarcinomaNCT06537193Asan Medical Center455
招募中
2 期
Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver CancerResectable Intrahepatic CholangiocarcinomaNCT05265208Center Eugene Marquis62
已完成
不适用
Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?Surgical TreatmentHepatectomyCholangiocarcinomaNCT00733200Huazhong University of Science and Technology